Submit an Inquiry

IMMY's tests, including tests for histoplasmosis, cryptococcosis, and coccidioidomycosis, have enabled early and rapid diagnosis. This has provided patients with timely treatment, directly impacting on their survival.
Dr. Lisandra Serra Damasceno, PhD
Federal University of Ceará and Sao José Hospital

Customer Testimonials

See how IMMY’s diagnostics are making a real difference—helping hospitals, labs, and healthcare providers improve patient outcomes with fast, reliable testing.

"We have been using IMMY diagnostic methods for over 10 years in our hospital, and they have had a profoundly positive impact on our institution. we have expanded our diagnostic capabilities by incorporating ELISA techniques for aspergillosis and histoplasmosis, as well as lateral flow methods for the diagnosis of cryptococcosis, histoplasmosis, and aspergillosis. These advancements have significantly reduced the time to diagnosis for these conditions, lowered mortality rates for histoplasmosis and cryptococcosis, and allowed us to implement both preventive and palliative treatments more effectively.

In addition, we utilize antigen quantification to monitor disease progression, predict severity, and guide treatment decisions. The incorporation of IMMY methods has had a substantially positive impact on our institution, and we hope other laboratories and hospitals in our country can adopt these methods as well."

Emmanuel Marin
Hospital F. J. Muñiz

Customer Testimonials

See how IMMY’s diagnostics are making a real difference—helping hospitals, labs, and healthcare providers improve patient outcomes with fast, reliable testing.